AUTOLOGOUS STEM CELL TRANSPLANTATION AS FRONT LINE THERAPY DOES NOT IMPROVE THE OUTCOME OF HIGH RISK AGGRESSIVE NON-HODGKIN'S LYMPHOMA: A SINGLE CENTER STUDY

被引：0
|
作者：
Won, J. -H [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ]
Kim, K. H. [1 ]
Kim, S. -H [1 ]
Lee, S. -C [1 ]
Kim, H. J. [1 ]
Bae, S. B. [1 ]
Kim, C. K. [1 ]
Lee, N. S. [1 ]
Lee, K. -T [1 ]
Park, S. K. [1 ]
Hong, D. S. [1 ]
Park, H. S. [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
271
引用
收藏
页码：S252 / S252
页数：1
相关论文
共 50 条
  • [31] Outcome of allogeneic stem cell transplantation for hodgkin and non-hodgkin lymphoma: Single center experince from Turkey
    Uysal, Ayse
    Bulbul, Hale
    Soyer, Nur Akad
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    Vural, Filiz
    BONE MARROW TRANSPLANTATION, 2019, 54 : 382 - 383
  • [32] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 457 - 464
  • [33] Allogeneic or autologous haematopoietic stem cell transplantation for non-Hodgkin lymphoma: status at transplantation and outcome
    Ferrant, A
    Van den Neste, E
    Michaux, L
    Durbecq, J
    Latinne, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S36 - S36
  • [34] Impact of AECC regiment with autologous stem cell transplantation for patients with high risk of relapse and refractory aggressive non-Hodgkin's lymphoma.
    Yano, S
    Asai, O
    Dobashi, N
    Sugiyama, K
    Saito, T
    Sekiguchi, N
    Kato, A
    Yahagi, Y
    Hoshi, Y
    Usui, N
    Kobayashi, M
    BLOOD, 2002, 100 (11) : 473B - 474B
  • [35] High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma:: a meta-analysis
    Strehl, J
    Mey, U
    Glasmacher, A
    Djulbegovic, B
    Mayr, C
    Gorschlüter, M
    Ziske, C
    Schmidt-Wolf, IGH
    HAEMATOLOGICA, 2003, 88 (11) : 1304 - 1315
  • [36] Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
    Salles, G
    Coiffier, B
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 151 - 169
  • [37] HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)
    Krishnan, Amrita
    Palmer, Joycelynne M.
    Zaia, John A.
    Tsai, Ni-Chun
    Alvarnas, Joseph
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1302 - 1308
  • [38] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [39] Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma
    Tsirigotis, Panagiotis
    Dray, Liliane
    Resnick, Igor B.
    Ackerstein, Aliza
    Gesundheit, Benjamin
    Elad, Sharon
    Or, Reuven
    Shapira, Michael-Yechiel
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 263 - 272
  • [40] A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome
    Fanin, R
    Sperotto, A
    De Elvira, CR
    Zaja, F
    Stocchi, R
    Geromin, A
    Cerno, M
    Patriarca, F
    Canelles, MF
    Damiani, D
    Baccarani, M
    HAEMATOLOGICA, 2000, 85 (09) : 943 - 951
12345